This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n10http://linked.opendata.cz/resource/drugbank/drug/DB04090/identifier/chemspider/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://bio2rdf.org/drugbank:
n8http://linked.opendata.cz/resource/drugbank/drug/DB04090/identifier/pdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB04090/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n14http://linked.opendata.cz/resource/drugbank/drug/DB04090/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://linked.opendata.cz/resource/drugbank/drug/DB04090/identifier/drugbank/
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04090
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB04090 n13:DB04090
dcterms:title
2,5-Diaziridin-1-Yl-3-(Hydroxymethyl)-6-Methylcyclohexa-2,5-Diene-1,4-Dione
adms:identifier
n8:RH1 n9:394347 n10:349539 n12:DB04090 n14:46504603
n5:IUPAC-Name
n6:271B6054-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B605A-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B6059-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B6056-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B6057-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B6058-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B6052-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B6050-363D-11E5-9242-09173F13E4C5 n6:271B6053-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B6051-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B6060-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B6061-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B605B-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B605C-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B605E-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B605D-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B605F-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B6066-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B6068-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B6069-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B6065-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B6064-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B6067-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B6055-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B6062-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B6063-363D-11E5-9242-09173F13E4C5